Partial therapeutic response to Rituximab for the treatment of chronic alloantibody mediated rejection of kidney allografts()

BACKGROUND AND OBJECTIVES: Chronic rejection leads to kidney allograft failure and develops in many kidney transplant recipients. One cause of chronic rejection, chronic antibody mediated rejection (CAMR), is attributed to alloantibodies. Maintenance immunosuppression including prednisone, mycopheno...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Smith, R. Neal, Malik, Fahim, Goes, Nelson, Farris, Alton B., Zorn, Emmanuel, Saidman, Susan, Tolkoff-Rubin, Nina, Puri, Sonika, Wong, Waichi
Formato: Artigo
Lenguaje:Inglês
Publicado: 2012
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC3728650/
https://ncbi.nlm.nih.gov/pubmed/22960786
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.trim.2012.08.005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares